Eliquis Regulatory Post Marketing Surveillance

Completed

Phase N/A Results N/A

Summary of Purpose

The primary objective of this study is to examine the safety profile of Eliquis in Korean nonvalvular atrial fibrillation patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 October 2017.

10 Jul 2013 21 Jun 2013 29 Sep 2017 29 Sep 2017 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Observation: Case-Only
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Contacts

  • Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email:

    Clinical.Trials@bms.com

  • First line of the email MUST contain NCT# and Site #.